Envirotainer sees a 24% rise in pharma volumes in 2022

Written by: Samantha Payne Polepaka |
Comment on this article

Envirotainer has reported a 24% increase in the volume of life-saving medicines shipped around the world in its temperature-controlled units.

In 2021, the Envirotainer fleet moved 600 million doses but in 2022 this grew to 744 million doses (272,000 pallets).

The news comes just months after Envirotainer extensively expanded its production site in Rosersberg, just north of Stockholm in November 2022.

Already the largest site in the world in terms of output, the investment will allow Envirotainer to grow its current fleet of 7,500 FAA and EASA certified containers by another 1,300 in 2023.

With its Releye range, Envirotainer can ensure minimal or zero temperature deviations on the shipments and virtually zero product loss.

Fredrik Linnér, Chief Business Development Officer at Envirotainer said, “The increase in our shipments reflects the huge need for efficient, secure and sustainable cold-chain solutions for transporting sensitive pharmaceuticals. We will continue to increase capacity, developing our product range and accelerating the digitalisation of the cold-chain industry. The need to safely transport pharmaceuticals while minimising wasted space in precious air cargo is unlikely to go away and we will be ready to help our customers move life-saving medicines where they need to be.”

This material is protected by MA Business copyright see Terms and Conditions.
One-off usage is permitted but bulk copying is not. For multiple copies contact samantha@groundhandling.com


Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code